Fragment-Guided Discovery of Pyrazole Carboxylic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2 Related Factor 2 (KEAP1:NRF2) Protein−Protein Interaction
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fragment-Guided Discovery of Pyrazole Carboxylic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2 Related Factor 2 (KEAP1:NRF2) Protein−Protein Interaction
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 21, Pages 15949-15972
Publisher
American Chemical Society (ACS)
Online
2021-10-28
DOI
10.1021/acs.jmedchem.1c01351
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
- (2021) Jakob S. Pallesen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-to-Lead Medicinal Chemistry Publications in 2018
- (2020) Daniel A. Erlanson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Facts, Patterns and Principles in Drug Discovery: appraising the Rule of 5 with measured physicochemical data.
- (2020) Christopher P. Tinworth et al. JOURNAL OF MEDICINAL CHEMISTRY
- Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein–Protein Interaction
- (2020) Yong Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease
- (2020) Sharadha Dayalan Naidu et al. Open Biology
- Fragment-to-Lead Medicinal Chemistry Publications in 2019
- (2020) Wolfgang Jahnke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
- (2019) Antonio Cuadrado et al. NATURE REVIEWS DRUG DISCOVERY
- Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design
- (2019) Marc O’Reilly et al. DRUG DISCOVERY TODAY
- Structure–Activity and Structure–Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein–Protein Interaction
- (2019) Tom D. Heightman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor BI-4924 Disrupts Serine Biosynthesis
- (2019) Harald Weinstabl et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Comparative Assessment Study of Known Small-Molecule Keap1−Nrf2 Protein–Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity
- (2019) Kim T. Tran et al. JOURNAL OF MEDICINAL CHEMISTRY
- Using Physicochemical Measurements to Influence Better Compound Design
- (2019) Shenaz B. Bunally et al. SLAS Discovery
- Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators
- (2019) Bin Ma et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease is Enhanced by Nrf2 Agonists.
- (2018) Martin A Bewley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases
- (2018) Jakob S. Pallesen et al. JOURNAL OF MEDICINAL CHEMISTRY
- A hit deconstruction approach for the discovery of fetal hemoglobin inducers
- (2018) Andrew B. Benowitz et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach
- (2018) Nick Barton et al. JOURNAL OF MEDICINAL CHEMISTRY
- Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
- (2016) Thomas G. Davies et al. JOURNAL OF MEDICINAL CHEMISTRY
- Twenty years on: the impact of fragments on drug discovery
- (2016) Daniel A. Erlanson et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents
- (2015) Dhulfiqar Ali Abed et al. Acta Pharmaceutica Sinica B
- Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review
- (2014) Chunlin Zhuang et al. CURRENT MEDICINAL CHEMISTRY
- Keap Calm, and Carry on Covalently
- (2013) Anthony J. Wilson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
- (2012) Meijuan Zhang et al. PROGRESS IN NEUROBIOLOGY
- Evaluation of Taylor dispersion injections: Determining kinetic/affinity interaction constants and diffusion coefficients in label-free biosensing
- (2011) John G. Quinn ANALYTICAL BIOCHEMISTRY
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction
- (2011) Rowena Hancock et al. FREE RADICAL BIOLOGY AND MEDICINE
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease
- (2011) A. Boutten et al. TRENDS IN MOLECULAR MEDICINE
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Defining optimum lipophilicity and molecular weight ranges for drug candidates—Molecular weight dependent lower logD limits based on permeability
- (2009) Michael J. Waring BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting the Nrf2 pathway against cardiovascular disease
- (2009) Jinqing Li et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Nrf2 protects against airway disorders
- (2009) Hye-Youn Cho et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease
- (2008) Marcus J. Calkins et al. ANTIOXIDANTS & REDOX SIGNALING
- Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice
- (2008) T. E. Sussan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More